Sign in
4/A

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001209191-23-021542

Chief Financial Officer acquired 51,346 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Colgan Erin Chief Financial Officer 2023-02-15 Grant or award +30,046 57,732 D
Colgan Erin Chief Financial Officer 2023-02-15 Grant or award +21,300 79,032 D
Derivatives
Colgan Erin Chief Financial Officer 2023-02-15 Grant or award · Stock Option (Right to Buy) +90,000 90,000 D
Loading xslF345X04/doc4a.xml…